(VIANEWS) – Shares of Amicus Therapeutics (NASDAQ: FOLD) jumped by a staggering 25.98% in 7 days from $9.97 to $12.56 at 16:29 EST on Monday, after four sequential sessions in a row of gains. NASDAQ is falling 0.26% to $12,624.09, following the last session’s downward trend.
Amicus Therapeutics’s last close was $12.18, 4.02% below its 52-week high of $12.69.
Today’s last reported volume for Amicus Therapeutics is 2926228 which is 21.47% below its average volume of 3726506.
Amicus Therapeutics’s Sales
Amicus Therapeutics’s sales growth is 17% for the ongoing quarter and 14% for the next.
Amicus Therapeutics’s Revenue
Year-on-year quarterly revenue growth grew by 18.5%, now sitting on 317.83M for the twelve trailing months.
Amicus Therapeutics’s last week, last month’s, and last quarter’s current intraday variation average was 5.60%, 0.39%, and 3.38%, respectively.
Amicus Therapeutics’s highest amplitude of average volatility was 5.60% (last week), 2.76% (last month), and 3.38% (last quarter), respectively.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Amicus Therapeutics’s stock is considered to be oversold (<=20).
Amicus Therapeutics’s Stock Yearly Top and Bottom Value
Amicus Therapeutics’s stock is valued at $12.56 at 16:29 EST, under its 52-week high of $12.69 and way higher than its 52-week low of $5.91.
Amicus Therapeutics’s Moving Average
Amicus Therapeutics’s value is way higher than its 50-day moving average of $9.86 and way higher than its 200-day moving average of $9.66.
More news about Amicus Therapeutics (FOLD).